These detection times vary with each drug and personal factors, such as individual metabolism
The second is dose and route translation : even where an effect is real in a mouse, the human-equivalent dose is not a simple body-weight scaling, and as the route section above stressed there is no human bioavailability figure to anchor an oral-versus-injected comparison
Really skeptical
For inflammatory bowel disease, mesalamine, corticosteroids, immunomodulators (azathioprine, methotrexate), and biologics (infliximab, adalimumab, vedolizumab, ustekinumab) all have Level 1 evidence from Phase III trials with thousands of patients
But ferritin tells the difference: Iron deficiency anemia Low ferritin (below 30 mcg/L) Anemia of chronic disease Normal or high ferritin (above 100 mcg/L) When ferritin falls in the middle range (30 to 100 mcg/L), the patient may have both conditions
SMA SMA Peptide